Listen for Patients Worried About Cancer Risk With Blood Pressure Meds

January 2019

Questions are cropping up about whether blood pressure meds cause cancer...because of a laundry list of recalls and media reports.

Contamination with a probable carcinogen is leading to ongoing recalls with valsartan, irbesartan, losartan, and some combo products.

Now patients are also hearing that some BP meds themselves are linked to cancer...NOT because of a contaminant.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Insurance Work Through "Step-Therapy" Rejections Efficiently
Medication Errors Prevent Mix-Ups Between Lamotrigine and Labetalol
Asthma Watch for Patients Getting OTC Primatene Mist for Asthma
Antihypertensives Listen for Patients Worried About Cancer Risk With Blood Pressure Meds
Cholesterol Ensure Patients Get the Right Statin Add-On
Cholesterol Anticipate More Patients Getting Vascepa to Help Reduce Heart Events
Antibiotics Keep an Eye Out for the New Tetracycline Antibiotic Nuzyra
Oral Health Help Patients With Non-Opioid Options for Dental Pain
Antiarrhythmics Keep Patients Taking Amiodarone Safe
MRSA Don't Automatically Substitute Generic Mupirocin for Bactroban Nasal
Supplements Be Ready for Questions About Eye Supplements for Blue Light
Epinephrine Know How the New EpiPen Generic Compares to Other Epinephrine Auto-Injectors